+182.6%
ABBV vs THC
+250.3%
-67.7%
-21.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.4% | +0.6% | -2.0% | -1.5% |
| 7D | +0.4% | -0.7% | +1.0% | +0.4% |
| 30D | +4.2% | +1.3% | +2.9% | +4.0% |
| 3M | +14.8% | +64.2% | -49.4% | +10.3% |
| 6M | +10.3% | +8.3% | +2.0% | +9.1% |
| YTD | +14.9% | +33.4% | -18.5% | +11.8% |
| 1Y | +24.1% | +37.7% | -13.5% | +20.3% |
| 3Y | +91.9% | +236.8% | -144.8% | +70.7% |
| All | +182.6% | +250.3% | -67.7% | +153.4% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling